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Abstract  
Asthma is one of the most common diseases in the world affecting more than 
10% of adults in many westernized countries and 339 million globally. Studies have 
shown a positive association between increased dietary fiber and improvement in 
asthma-related inflammation. Omega-3 fatty acids have also been shown to help 
mitigate inflammation in general. No identified studies have looked at the synergistic 
effect of omega-3 and omega-6 fatty acids alone and as a ratio with fiber on asthma, 
lung function, and respiratory morbidities. A positive association could mean that dietary 
interventions of fiber and fatty acids could significantly improve asthma and asthma-
related symptoms. Dietary interventions are especially attractive because they are 
inexpensive and can be easy to incorporate into daily routines. Using data from 
NHANES from year cycles 2007-2012, analysis through logistic regression was 
performed to find the association of the synergistic effect of fiber and the omega-
6:omega-3 fatty acid ratio on asthma and asthma-related symptoms in an adult U.S. 
population. Intake of fiber was found to be associated with cough (p-value=0.02), but 
 
that there was no significant association of omega-3 or omega-6 fatty acids with asthma 
or asthma-related symptoms either alone or as a ratio. The role of omega-6 fatty acids 
in inflammation, whether pro- or anti-inflammatory, is still not fully understood, but even 
less is understood about the complex relationship between omega-3 fatty acids and 
omega-6 fatty acids. The understanding of the interaction of fiber and omega fatty acids 
on asthma and asthma-related symptoms requires further study.  
 
Background 
Asthma is a chronic inflammatory disease of the airways. Symptoms include 
wheezing, breathlessness, chest tightness, sputum production, coughing (that varies 
over time and intensity), and a variable expiratory airflow limitation (via a spirometry 
test).1,2 Asthma is one of the most common diseases in the world affecting more than 
10% of adults in many westernized countries and 339 million globally.3,4,5 In the U.S., 
asthma prevalence is 8.3%.4   
The total economic burden of asthma in the U.S., in 2008-2013, was $81.9 billion 
and includes costs for both children and adults comprising medical costs, absenteeism, 
and mortality costs.6 In fact, 1.8 additional work days and 2.3 additional school days 
were missed due to asthma during 2008-2013.6 The annual incremental medical cost of 
asthma per-person is projected to be $4,699.7 In addition to economic losses, there are 
negative effects to quality of life related to asthma, demonstrated through significant 
quality of life year (QALY) losses. It is estimated that both adolescents and adults will 
lose 15.46 million QALY in the next 20 years, which is a 4.2% increase of loss, due to 
 
uncontrolled asthma.7 Because of these substantial losses, prevention, intervention, and 
treatment of asthma is critical. 
There are many phenotypes of asthma, rendering it a complex syndrome rather 
than a single disease.8 Some of these phenotypes include inflammatory (allergic versus 
non), immunological (atopic versus non), age of onset (child versus adult), related to 
genetic factors, related to comorbidities, related to triggering factors (like exercise), and 
clinical (episodic versus persistent).5  Allergic (inflammatory) and atopic (immunological) 
are the most common phenotypes, both often called type 2 asthma. In fact, half of adult 
asthma patients have allergic asthma.2 Although prevention of asthma is important, it is 
difficult for many reasons, to include a wide range of risk factors, many of which are 
unmodifiable. In addition to this, asthma is often under- and over-diagnosed.2,5 
Although there is no cure for asthma, knowing the phenotype of asthma can help 
guide the decision-making process for the most appropriate and effective intervention. 
Interventions such as pharmacological, immunotherapy, allergen avoidance, dietary, or 
a combination, can help lessen the severity and mitigate symptoms (see Figure 1).5 For 
example, the presence of immunoglobulin E (IgE), which has a fundamental role in the 
pathophysiology of asthma, is one of the most valuable indicators for allergic asthma. 
Once identified, understanding the allergens to which the patient is allergic to will help 
with effective avoidance, thus mitigating asthma symptoms.2 In another example, a 
mother being overweight during pregnancy has been associated with childhood 
asthma.9 A dietary intervention of fish oil for pregnant women from 20 weeks of 
gestation until delivery showed a reduction in asthma outcomes at one year for  
 
 
Figure 1. Factors influencing asthma endotypes and phenotypes. The interactions between immune 
responses and exposome (a measure of all exposures in an individual from birth until current time), 
microbiome, epigenome and genomes, allergen sensitization, and epithelial barrier all affect the asthma 
endotypes and phenotypes. 
Source: Ozdemir C, Kucuksezer UC, Akdis M, Akdis CA. The concepts of asthma endotypes and phenotypes to guide current and 
novel treatment strategies. Expert Rev Respir Med. 2018;12(9):733-43. 
 
children.5 Additionally, diet changes in those who already have asthma have a strong 
association with improvement of symptoms.4,5 Dietary interventions are especially 
attractive because they are inexpensive and easy to incorporate into daily routines.5 
A review by Calder exploring marine omega-3 fatty acids (FA) in inflammation, to 
include asthma, found that the intake of marine omega-3 fatty acids, i.e., 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), can help control the 
effects of inflammation.  When inflammation occurs, elevated levels of leukocytes 
concentrate at the site (here, we focus on the lungs) and release lipid-derived 
mediators, peptide mediators, reactive oxygen species, amino acid derivatives, and 
enzymes. This influx of cells at the site of inflammation, and subsequent mediators, 
generate the cardinal signs of inflammation: redness, swelling, heat, pain, and loss of 
function.10  Due to its prevalence in phospholipids, arachidonic acid (ARA), an omega-6 
 
FA, is often the substrate for eicosanoids.10 These eicosanoids, derived from ARA, are 
involved in determining the allergic predisposition to asthma, as well mediators involved 
in the inflammatory response.10 An increase in omega-6 FA (specifically ARA) and a 
reduction in omega-3 FA, has been correlated to increased incidence of asthma.11 
Thus, inhibiting ARA conversion from linoleic acid via competition of omega-3 FA could 
potentially improve inflammation related to asthma (see Figure 2). Additionally, both 
EPA and DHA have been shown to improve lung function by reducing eosinophil 




Figure 2. The parallel pathways of omega-3 and omega-6 and shared enzymes. ‘Des’ denotes 
desaturase and ‘elo’ denotes elongase. OA, oleic acid; LA, linoleic acid; GLA, γ-linolenic acid; DGLA, 
dihomo-γ-linolenic acid; ARA, arachidonic acid; DTA, docosatetraenoic acid; DPA6, ω6 
docosapentaenoic acid; ALA, α-linolenic acid; SDA, stearidonic acid; ETA, eicosatetraenoic acid; EPA, 
eicosapentaenoic acid; DPA, ω3 docosapentaenoic acid. 
Source: Petrie JR, Shrestha P, Belide S, Kennedy Y, Lester G, Liu Q, Divi UK, Mulder RJ, Mansour MP, Nichols PD, Singh SP. 
Metabolic engineering Camelina sativa with fish oil-like levels of DHA. PLoS One. 2014; 9(1):e85061.  
 
Recent studies have shown that dietary fiber exhibits both anti-inflammatory and 
antioxidant properties.12  Specifically, high-fiber has a protective role in asthma, 
respiratory morbidity (wheeze, cough, and phlegm), and systemic inflammation.  It has 
also been shown that dietary fiber changes the composition of the gut microbiome, 
particularly altering the ratio of Firmicutes and Bacteroidetes, thus increasing the 
concentration of short-chain fatty acids (SCFA). These SCFA, or the  by-products of 
fiber fermentation in the gastrointestinal tract by the gut microbiota, can be found in the 
systemic circulation and provide a protective effect on the lungs via regulation of 
neutrophils, attenuation of pulmonary inflammation, and epithelial-based protection 
against bacterial infections (see Figure 3).12 
 
Figure 3. The gut-lung axis. The gut microbiota can influence the lung microbiota by modulating lung 
immunity through bacterial ligands, bacterial metabolites, and migratory cells that then circulate 
systemically to the lungs. The lung microbiota is responsible for maintaining a healthy immune response. 
It is also possible that the immune response could regulate the lung microbiota, as indicated by the 
double-ended arrows.  
Source: Chung KF. Airway microbial dysbiosis in asthmatic patients: A target for prevention and treatment? J Allergy Clin Immunol. 
2017;139(4):1071-81. 
 
The recommended dietary requirement of fiber is 20-30 g/d, with positive results 
seen in asthma by Saeed et al. at levels above 21.2 g/d.4  An effective dose for EPA 
and DHA is recommended to be 2 g/d, but the required dose of the omega-3 and 
omega-6 FA ratio to be effective in asthma is still unclear.10 Additionally, the interaction 
between fiber and these FA, and their role in asthma, need further exploration. In fact, 
no identified studies have looked at the synergistic effect of omega-3 and omega-6 FA 
with fiber on asthma, lung function, and respiratory morbidities. We believe that 
although fiber and omega-3 FA are protective separately, their combined effect could be 
greater together and significantly improve asthma and asthma-related symptoms. 
 
Aims 
No identified studies have looked at the synergistic effect of both omega-6 and 
omega-3 FA with fiber on asthma, lung function, and respiratory morbidities. This study 
explored the effect of fiber and the omega-6:omega-3 FA ratio on asthma and asthma-
related symptoms in an adult U.S. population. We accomplished this objective through 
the following aim. 
Aim: Determine the moderating role of fiber intake: on the relationship of omega-6 and 
omega-3 FA with asthma, and asthma-related respiratory symptoms. We hypothesize 
that a lower omega-6:omega-3 FA ratio and increased fiber intake are associated with a 
decreased odds of asthma and asthma-related symptoms compared to those with a 





 The National Center for Health Statistics of the Center for Disease Control and 
Prevention (CDC) conducts the National Health and Nutrition Examination Survey 
(NHANES).13,14 This is an ongoing cross-sectional survey conducted nationwide 
designed to assess the health and nutritional status of the U.S. population that is not 
institutionalized. Study participants are selected by using stratified multistage probability 
sampling, including oversampling of minorities, low-income, and elderly subjects to 




We analyzed data from adults 20-79 years old with complete information on 
asthma, age, gender, race/ethnicity, education status, body mass index (BMI), smoking 
status, income to poverty ratio, fiber intake, and omega FA intake (Figure 4). Age (19 
years or younger and 80 years or older), pregnancy status (pregnant), and chronic 
obstructive pulmonary disease (COPD)/asthma-COPD Overlap Syndrome (ACOS) (the 
presence of) were used as exclusion criteria. Implausible caloric intake was deemed to 
be <600 or >6,000 kcal/d for women and <800 or >8,000 kcal/d for men. 4,15 Those 
missing data on asthma, age, gender, race/ethnicity, education status, BMI, smoking 




Figure 4.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) diagram. 
COPD is defined as 40 years of age or older, having smoked at least 100 cigarettes in lifetime, having a 
FEV1/FVC ratio of <0.7, and no asthma. Those with asthma-COPD overlap syndrome (ACOS) had the 
characteristics of someone with COPD, as previously stated, but also had answered yes to currently 
having asthma. Those with missing data, as shown above, were removed along with those out of the age 
range (<20 years and >80 years), pregnant, having implausible total calories, or having COPD or ACOS. 
 
Both asthma and COPD are common chronic lung diseases seen worldwide. 
These diseases, however, differ in pathogenesis, disease progression, prognosis, and 
 
treatment options.16 Asthma affects the small and large airways and is often 
accompanied by allergies. It typically develops in childhood, but may develop in 
adulthood for a small group of people. Generalized airway obstruction causes 
wheezing, coughing, chest tightness, and breathlessness. This airway obstruction is 
caused by smooth-muscle spasm and is reversible after the attack. Bronchial 
hyperresponsiveness, a key feature of asthma (but not sufficient for a firm diagnosis), is 
caused by inhaled stimuli.17  COPD affects mainly the small airways and is primarily 
caused by smoking. Due to its link to smoking, COPD is often seen in adults over 40 
years old and has poor life expectancy. Airway obstruction causes wheezing, chronic 
cough, breathlessness, and phlegm. This obstruction is caused by smooth-muscle 
contraction, airway mucus, or tissue breakdown, leading to a loss of lung elastic recoil 
that inhibits reversibility.17 Although heterogeneous diseases, similar symptoms shared 
between the two create overlap, causing distinction between the two diseases to be 
difficult.16,17 These shared symptoms include shortness of breath, cough, and sputum.16 
Additionally, some patients with asthma may experience irreversible airway damage 
and those with COPD reversible damage, contradicting what is typically seen.16,17  
Thus, relevant variables to consider for diagnosis of either asthma or COPD are: age of 
onset, pattern and time course of symptoms, personal/family history, variable/persistent 
airflow limitation, lung function between symptoms, and severe hyperinflation.17 If three 
or more features of either disease (asthma or COPD) is present, then it is commonly 
diagnosed as that disease.17 If there are similar number of features in a patient for both 
COPD and asthma, it is suggestive of ACOS.  
 
 
Asthma and Respiratory Symptoms 
Current asthma was defined as “yes” if participants answered positively to two 
questions: “Has a doctor or other health professional ever told you that you have 
asthma?” and “Do you still have asthma?” Participants were controls if they answered 
“no” to either question. Current wheeze was defined as a “yes” to the question: “In the 
past 12 months, have you had wheezing or whistling in your chest?” Chronic cough was 
defined as answering “yes” to the question: “Do you usually cough on most days for 
three consecutive months or more during the year?” Chronic phlegm was defined as 
answering “yes” to the question: “Do you bring up phlegm on most days for three 
consecutive months or more during the year?” 
 
Fiber and Omega Fatty Acid Intake 
 Intake of both fiber and omega FA was obtained via the NHANES 24-hour 
diet recall interview, using the average of day one and day two for both diet variables. 
The first dietary interview was collected in-person in the mobile examination center 
(MEC) using the Automated Multiple Pass Method from the U.S. Department of 
Agriculture.18 At the end of the MEC dietary interview, the interviewers schedule the 
participants for a phone follow-up interview. A follow-up dietary interview is conducted 
by telephone 3-10 days later. Detailed descriptions of dietary interview and data 
processing procedures can be found under the dietary interview components on the 
NHANES website.15 In this study, the goal is to rank individuals with respect to fiber and 
FA intake, rather than to make accurate estimates of absolute intake. Diet variable 
 
quartiles were based on the population. Fiber was categorized into quartiles (Q1 <11.15 
g/d; Q2 11.15-<15.7 g/d; Q3 15.7-<21.95 g/d;  Q4 >21.95 g/d). Omega FA was defined 
as intake of omega-3 and omega-6 or as a ratio (omega-6:omega-3). Omega-3 in this 
study was defined as intake of octadecatrienoic acid (18:3 ALA), octadecatetraenoic 
acid (18:4 SDA), EPA (20:5), docosapentanoic acid (22:5 DPA), and DHA (22:6). 
Omega-6 was defined as intake of octadecadienoic acid (18:2 LA) and ARA (20:4).  
NHANES did not define what isomers ALA, DPA, and ARA are, thus determining 
whether omega-3 or omega-6. Thus, based on previous research, they were 
categorized in this study as stated above.19-27 Fatty acid intake was categorized into 
quartiles (Quartiles for total omega-3 are: Q1 <1.07 g/d; Q2 1.07-<1.54 g/d; Q3 1.54-
<2.22 g/d; Q4 >2.22 g/d. Quartiles for omega-6 are: Q1 <10.07 g/d; Q2 10.07-<14.53 
g/d; Q3 14.53-<20.35 g/d; Q4 >20.35 g/d. Quartiles for omega-6:omega-3 ratio are: Q1 
<7.77; Q2 7.77-<9.16; Q3 9.16-<10.95; Q4 >10.95). 
 
Additional Covariates 
 Covariates included in our adjusted models are age, gender, race/ethnicity, 
income to poverty ratio, BMI, smoking status, and education. These covariates were 
defined from previous literature.4 The correlation between diet and physical activity was 
examined in the study population and there was not a significant correlation found. 
Additionally, use of physical activity as a covariate would have brought the study 
population to 2,469 participants. Age was categorized as: 20-39 years, 40-59 years, and 
60+ years. Race/ethnicity was categorized as: non-Hispanic white, non-Hispanic black, 
Mexican American and other Hispanic, and Other (to include multiracial). Socio-
 
economic status was determined by the poverty to income ratio, which was categorized 
as: <1(poverty), 1-2.9, and 3-5+. BMI status was categorized as: underweight (<18.5 
kg/m2), normal (18.5-24.9 kg/m2), overweight (25-29.9 kg/m2), and obese (30-40 kg/m2). 
Smoking status was defined as: never, former (smoked>100 cigarettes in a lifetime, but 
does not currently smoke), and current (smoked>100 cigarettes in a lifetime and 
currently smokes). Lastly, education was grouped into three categories: less than high 
school graduate, high school graduate/GED, and college (to include some college or AA 
and college graduate or above). 
 
Statistical Analysis 
 Statistical analysis was done in SAS 9.4. Descriptive statistics (frequency, mean, 
median, and standard deviation) were performed on demographic variables of age, 
gender, race/ethnicity, income to poverty ratio, BMI, smoking status, and education. 
Bivariate analysis was used to determine the association between fiber, omega FA, and 
demographics variables. Chi-square test was used to assess associations between 
outcome variables ([yes/no]: asthma, wheeze, cough, phlegm) and exposure variables 
(fiber and omega FA quartiles, and FA ratio). PROC SURVEYMEANS and PROC 
SURVEYFREQ were used for descriptive analysis of the population and associations 
for continuous and categorical variables, respectively. Finally, multivariable logistic 
regression was applied to examine the relationship of fiber, omega FA ratio, and FA 
quartiles with the odds of developing asthma, wheeze, cough, and phlegm using PROC 
SURVEYLOGISTIC after controlling for age, gender, race/ethnicity, income to poverty 
ratio, BMI, total energy intake (continuous), and smoking status. Fiber was tested as an 
 
interaction term with omega-3 FA, omega-6 FA, and the FA ratio. Ptrend was determined 
by using PROC SURVEYLOGISTIC and setting the diet variable (either fiber, omega-3 
FA, or omega-6 FA) as continuous, rather than categorical.  For all tests, significance is 
set at two-sided p-value<0.05. 
 
Results 
 After exclusion criteria were applied to the NHANES population (n=28,237) our 
study population included 10,028 individuals (see Figure 4). The mean age was 
44.2+0.4 (SD) years with 53.3% female and 46.7% male (see Table 1). The mean 
income to poverty ratio was 3.3+0.04 (SD) and the majority of subjects were non-
Hispanic white (69%), had at least some college (63%), and never smokers (63%). 
Nearly 70% of all subjects were either overweight or obese with a mean BMI of 28.97 
kg/m2+0.12 (SD). When compared to controls (no asthma), those with asthma tended to 
be female (65.3% versus 52.4%), in poverty (22.5% versus 13.9%), and obese (48.0% 
versus 35.8%).  
 The association of intake of fiber and omega FA with asthma was determined by 
bivariate analysis. Intake of fiber was associated with lower odds of asthma (p-
value=0.0016). This association, however, was lost in multivariable analysis. Although 
not statistically significant, those with asthma were more likely to have lower intake of 
fiber than those with no asthma, with over 54% of asthmatics consuming fiber in the 
lower two quartiles, while 48% of those with no asthma had similar intake levels (mean 
for those with asthma compared to no asthma, 16.22+0.52 g/d and 17.47+0.22 g/d,  
 








 10028 719(7.02) 9309(92.98)  
Age, years    0.0551 
  20-39  4009(41.67) 314(44.81) 3695(41.44)  
  40-59  3425(38.48) 216(32.97) 3209(38.89)  
  60+  294(19.85) 189(22.22) 2405(19.67)  
     
Gender    <.0001 
  Male 4648(46.66) 237(34.70) 4411(47.57)  
  Female 5380(53.34) 482(65.30) 4898(52.43)  
     
Race/Ethnicity    0.0045 
  Non-Hispanic white 4377(68.99) 353(71.24) 4024(68.82)  
  Non-Hispanic black 2166(11.10) 187(13.90) 1979(10.89)  
  Mexican American and other Hispanic 2654(13.76) 133(9.78) 2521(14.06)  
  Other, including multiracial 831(6.15) 46(5.08) 785(6.23)  
     
Education    0.5177 
  Less than high school grad 2350(15.34) 155(13.81) 2195(15.45)  
  High school grad/GED equivalent 2188(21.26) 165(22.04) 2023(21.21)  
  College (some/AA degree to graduate) 5490(63.40) 399(64.15) 5091(63.34)  
     
Ratio of income to poverty*    <.0001 
   <1 2183(14.47) 228(22.50) 1955(13.87)  
   1-2.9 4011(34.16) 264(31.90) 3747(34.33)  
   3-5+ 3834(51.37) 227(45.60) 3607(51.80)  
     
BMI, kg/m2    <.0001 
  Underweight, <18.5 129(1.36) 2(0.16) 127(1.45)  
  Normal, 18.5-24.9 2643(28.49) 141(22.43) 2502(28.95)  
  Overweight, 25-29.9 3303(33.45) 193(29.38) 3110(33.75)  
  Obese, 30-40+ 3953(36.70) 383(48.03) 3570(35.85)  
     
Smoking Status    0.1316 
  Never smoker 6265(62.76) 424(61.15) 5841(62.88)  
  Former Smoker 1927(20.04) 129(18.16) 1798(20.18)  
  Current Smoker 1836(17.20) 166(20.69) 1670(16.94)  
     
Wheeze     <.0001 
  yes 1217(11.48) 428(58.82) 789(7.90)  
  no 8801(88.52) 291(41.18) 8510(92.10)  
     
Chronic Cough    <.0001 
  yes 512(8.41) 113(27.23) 399(7.07)  
  no 5500(91.59) 291(72.77) 5209(92.93)  
     
Chronic Phlegm     <.0001 
  yes 423(5.97) 86(17.90) 337(5.12)  
  no 5592(94.03) 318(82.10) 5274(94.88)  
 
*Under one means in poverty; BMI= body mass index. PROC SURVEYFREQ used for analysis. Wheeze         
(total=10,018), Cough (total=6,012), Phlegm (total=6,015). 
 
 
               Table 2. Association of intake of fiber and omega fatty acids with asthma 
Diet variable Total Asthma  No Asthma  p-value 
 10028 719 9309  
Fiber     0.0016 
Q1 (<11.15 g/d) 2657(23.82) 246(31.16) 2411(23.27)  
Q2 (11.15-<15.7 g/d) 2546(25.25) 176(23.77) 2370(25.36)  
Q3 (15.7-<21.95 g/d) 2465(25.64) 169(23.51) 2296(25.80)  
Q4 (>21.95 g/d) 2360(25.29) 128(21.56) 2232(25.57)  
Mean + stnd err 17.57+0.203 16.22+0.52 17.48+0.22  
     
Total omega-3    0.1702 
Q1 (<1.07 g/d) 2713(24.23) 221(26.90) 2492(24.03)  
Q2 (1.07-<1.54 g/d) 2541(25.27) 187(27.48) 2354(25.10)  
Q3 (1.54-<2.22 g/d) 2412(24.83) 168(23.54) 2244(24.93)  
Q4  (>2.22 g/d) 2362(25.67) 143(22.08) 2219(25.94)  
Mean + stnd err 1.78+0.014 1.68+0.06 1.78+0.01  
     
Total omega-6    0.4054 
Q1 (<10.07 g/d) 2822(24.27) 215(25.74) 2607(24.15)  
Q2 (10.07-<14.53 g/d) 2492(25.00) 183(26.90) 2308(24.85)  
Q3 (14.53-<20.35 g/d) 2426(25.26) 167(24.94) 2259(25.29)  
Q4 (>20.35 g/d) 2289(25.47) 154(22.42) 2135(25.71)  
Mean + stnd err 16.25+0.12 15.23+0.41 16.27+0.13  
     
Omega ratio n6:n3    0.6362 
Q1 (<7.77) 2672(24.81) 176(24.01) 2496(24.88)  
Q2 (7.77-<9.16) 2443(24.63) 182(25.64) 2261(24.55)  
Q3 (9.16-<10.95) 2427(24.86) 160(22.56) 2267(25.03)  
Q4 (>10.95) 2486(25.70) 201(27.79) 2285(25.54)  
Mean + stnd err 9.79+0.05 9.68+0.14 9.76+0.06  
                PROC SURVEYFREQ and PROC SURVEYMEANS used for analysis.  
 
respectively) (see Table 2). This same trend was seen with omega-3 FA intake as well. 
Those with asthma tended to have less omega-3 FA intake than those with no asthma 
with over 54% of asthmatics consuming omega-3 FA in the lower two quartiles, while 
 
49% of those with no asthma had similar intake values (mean for those with asthma 
compared to no asthma, 1.68+0.06 g/d and 1.78+0.01 g/d, respectively). Unlike fiber 
and omega-3 FA, lower levels of omega-6 FA are desirable since higher levels are 
thought to contribute to inflammatory diseases such as asthma.11,28 When comparing 
the two higher quartiles of omega-6 FA (Q3 14.53-<20.35 g/d; Q4 >20.35 g/d) between 
those with asthma and those with no asthma, surprisingly, those with asthma consumed 
less omega-6 FA than those with no asthma, 47.4% versus 51%, respectively (mean of 
15.23+0.41 g/d versus 16.27+0.13 g/d). When comparing the two higher quartiles of the 
FA ratios (Q3 9.16-<10.95; Q4 >10.95)  between those with asthma and those with no 
asthma, there were nearly identical amounts of subjects in these higher quartiles, 50.3% 
versus 50.6%, with a mean of 9.68+0.14 versus 9.76+0.06, respectively. Although 
notable, the association of asthma with omega FA and FA ratio was not statistically 
significant. 
 Multivariable analysis did not show any significant association between diet 
variables and respiratory outcomes except for fiber intake and cough (see Table 3). 
Lower fiber intake (Q1) showed increased odds of cough (OR=1.8, 95% CI 1.21-2.77, p-
value=0.005) when compared to higher fiber intake (Q4). A linear trend was also 
observed for fiber intake and cough (ptrend=0.008). Although not significant, a trend 
between fiber intake and phlegm was also seen, with higher odds of experiencing 
phlegm with lower fiber intake (Q1 OR=1.5, CI 1.00-2.39; Q2 OR=1.3, CI 0.82-2.15; Q3 




Table 3. Relationship of fiber and omega fatty acid quartiles with asthma and respiratory symptoms 
Diet variable Asthma  Phlegm Cough Wheeze 
  10028 6015 6012 10018 
Fiber      
Q1 (<11.15 g/d) 1.2(0.86-1.57) 1.5(1.00-2.39) 1.8(1.21-2.77) 1.2(0.92-1.51) 
Q2 (11.15-<15.7 g/d) 0.9(0.70-1.15) 1.3(0.82-2.15) 1.6(1.17-2.23) 1.2(0.96-1.55) 
Q3 (15.7-<21.95 g/d) 0.9(0.70-1.27) 1.1(0.68-1.77) 1.3(1.06-1.74) 1.1(0.86-1.44) 
Q4 (>21.95 g/d) 1 1 1 1 
Overall p-value 0.15 0.1 0.02 0.39 
Q1 vs. Q4 p-value 0.32 0.05 0.005 0.18 
P trend 0.92 0.17 0.008 0.11 
          
Total omega-3         
Q1 (<1.07 g/d) 1.0(0.72-1.36) 1.0(0.61-1.75) 0.8(0.58-1.14) 1.0(0.73-1.38) 
Q2 (1.07-<1.54 g/d) 1.1(0.81-1.46) 1.0(0.63-1.57) 0.9(0.64-1.32) 1.1(0.88-1.38) 
Q3 (1.54-<2.22 g/d) 1.0(0.77-1.32) 0.9(0.66-1.50) 0.7(0.55-1.10) 0.9(0.82-1.21) 
Q4 (>2.22 g/d) 1 1 1 1 
Overall p-value 0.87 0.99 0.53 0.8 
Q1 vs. Q4 p-value 0.95 0.9 0.23 0.99 
P trend 0.64 0.86 0.68 0.91 
          
Total omega-6         
Q1 (<10.07 g/d) 1 1 1 1 
Q2 (10.07-<14.53 g/d) 1.2(0.87-1.53) 1.1(0.74-1.69)      0.9(0.68-1.4) 1.1(0.85-1.53) 
Q3 (14.53-<20.35 g/d) 1.1(0.80-1.57) 1.0(0.63-1.73)      1.1(0.75-1.65) 1.0(0.82-1.33) 
Q4 (>20.35 g/d) 1.1(0.79-1.56) 1.2(0.61-2.17)      1.3(0.79-2.11) 1.1(0.77-1.44) 
Overall p-value 0.81 0.93 0.64 0.83 
Q1 vs. Q4 p-value 0.55 0.67 0.31 0.74 
P trend 0.98 0.99 0.57 0.4 
          
Omega ratio n6:n3       
Q1 (<7.77) 1 1 1 1 
Q2 (7.77-<9.16) 1.0(0.76-1.40) 1.4(0.92-2.07) 1.4(1.00-2.07) 1.0(0.78-1.31) 
Q3 (9.16-<10.95) 0.9(0.66-1.18) 1.3(0.81-2.04) 1.0(0.69-1.49) 0.8(0.65-1.08) 
Q4 (>10.95) 1.1(0.81-1.43) 0.9(0.57-1.34) 1.1(0.74-1.50) 1.0(0.84-1.25) 
Overall p-value 0.68 0.22 0.06 0.35 
Q1 vs. Q4 p-value 0.61 0.52 0.78 0.82 
P trend 0.92 0.41 0.79 0.36 
PROC SURVEYLOGISTIC used for analysis. Adjusted for age (20-39 years, 40-59 years, 
and 60+ years), gender, race/ethnicity (non-Hispanic white, non-Hispanic black, Mexican 
American and other Hispanic, and Other), income to poverty ratio (<1, 1-2.9, and 3-5+), 
BMI (underweight, <18.5 kg/m2; normal, 18.5-24.9 kg/m2; overweight, 25-29.9 kg/m2; and 






 We explored the association of fiber, omega-3, and omega-6 FA intake with 
asthma and asthma-related symptoms in a population-based study of 10,028 individuals 
from NHANES (2007-2012). In the bivariate analysis, we found that higher intake of 
fiber was associated with decreased odds of asthma; however, only the relationship 
between fiber and cough was significant in multivariable analysis. There was no 
significant association of omega-3 or omega-6 FA with asthma or asthma-related 
symptoms.  
Alwarith et al. noted that diets comprised of high fat and low fiber are associated 
with airway inflammation and decreased lung function in asthmatics.11 In support of this, 
previous research has shown that higher levels of fiber intake are correlated with lower 
odds of experiencing an exacerbation of asthma and respiratory symptoms.3,4 While we 
did not observe a strong association between fiber and cough, phlegm or wheeze in 
bivariate analysis, an inverse association was seen between fiber and cough in the 
multivariable analysis. These results are slightly different than our previous study by 
Saeed et al. where we found that lower levels of fiber increased the odds of asthma and 
asthma-related symptoms (wheeze, cough, phlegm, and chronic bronchitis).4 While the 
results seem contradictory, the NHANES population used in the two studies differed. 
Both studies used the definition of asthma; however, Saeed et al. included individuals 
with asthma as well as those with COPD in their study population. The current study 
removed individuals with COPD as defined as having a FEV1/FVC<0.7 and were current 
or former smokers. Asthma is epidemiologically difficult to study because of its 
heterogeneous nature and lack of standard definition or gold standard diagnostic test. 
 
To compound this challenge, clinical characteristics of asthma and COPD sometimes 
overlap (thus, diagnosed as ACOS) or are experienced concomitantly. Those 
experiencing COPD, either alone or as ACOS, often have behavioral differences and 
notably different demographic characteristics when compared to those experiencing 
asthma alone. Specifically, those with COPD tend to be smokers (current or former), 
over the age of 40, and male.16,17,21 Eliminating those with COPD from the current study 
population ensured we did not skew our analysis or spuriously attribute certain 
characteristics to our defined groups of asthma and no asthma. It is likely that Saeed et 
al. saw significant associations between fiber, asthma, and respiratory symptoms 
because their population contained subjects with COPD and/or ACOS. 
The National Institutes for Health (NIH) state that optimum levels of fiber intake 
are 38 g/d for males and 25 g/d for females.29  The NIH also noted that in 2010 the U.S. 
average intake for fiber was only 14 g/d.29 In our study, no subjects met the fiber 
recommendations set by the NIH, but nearly 32% had a fiber intake of >20g/d. These 
fiber intake values are similar in the Saeed study where only 33% of their subjects met 
their cited recommendation of 20 g/d.4  
Omega-3 FA have been shown to have anti-inflammatory properties and thought 
to reduce the risk of cardiovascular disease, improve infant health and 
neurodevelopment, prevent cancer, and positively affect Alzheimer’s disease, dementia, 
cognitive function, age-related macular degeneration, dry eye disease, and rheumatoid 
arthritis.19,21,30 We did not, however, observe an association of omega-3 FA with asthma 
or asthma-related symptoms. These results are similar to those found by Kumar et al. 
where they found in a Dutch population-based study that omega-3 FA did not protect 
 
against asthma.31 However, another population-based study in Northern Europe found 
that a minimum weekly intake of fish high in omega-3 FA was protective for asthma.31 
The inconsistencies found in these studies, as well as our own, may be due to 
inaccuracies inherent to dietary recall methods used in population-based studies.31 
While there is no set recommendation for daily intake for any omega-3 FA, the 
NIH has suggested adequate intake (AI) (or the intake level that is assumed to be 
nutritionally adequate) for ALA as 1.6 g/d for adult males and 1.1 g/d for adult females.32 
In our study, 24% of males and 33% of females met the recommended AI for ALA. 
Because only ALA is considered essential, there are no AIs stated for any other omega-
3, to include EPA or DHA.32  Calder et al., however, found that resolution can be seen in 
inflammation when EPA and DHA intake levels are at 2 g/d and positive effects of 
omega-3 FA are seen on asthma when intake levels of EPA and DHA were above 2 
g/d.10 Intake of >2 g/d of EPA and DHA was only seen in 0.2% of our population. It 
should be noted that while EPA and DHA can be converted from ALA, the conversion 
rate is incredibly poor in humans.10 
The role of omega-6 FA in inflammation and respiratory outcomes, like asthma, 
is unclear. While many believe these FA to be pro-inflammatory, studies have shown 
that increasing intake of omega-6 FA did not actually affect many inflammatory 
biomarkers.33 In fact, some epidemiological studies have suggested that omega-6 FA 
can even reduce inflammation.33 Additionally, there is evidence that omega-6 FA inhibit 
the anti-inflammatory effects of omega-3 FA, creating a complex interaction between 
the two FA.33 Western diets are laden with omega-6 FA; thus, a deficiency of omega-6 
FA is rarely a problem.11 Like ALA, LA is the omega-6 precursor to ARA, and is 
 
considered an essential FA.32 The NIH recommends that daily intake for adults are 17 
g/d for males and 12 g/d for females.34 Many agree, however, that it is more important 
to increase omega-3 intake than it is to decrease omega-6 levels.32 In our study, 23% of 
males and 29% of females consumed levels of LA at or above those recommended by 
the NIH. However, when stratified by asthmatic status, those with no asthma consumed 
less omega-6 FA compared to those with asthma (mean 15.23 g/d versus 16.27 g/d, 
respectively). A study by McKeever et al. showed similar results where they looked at 
omega FA intake in 13,820 adults and its association with asthma symptoms. The 
researchers found that higher levels of omega-6 FA, not omega-3 FA, were associated 
with a higher FEV1.35 
In this study, dietary omega-3 FA was determined based on intake of ALA, SDA, 
EPA, DPA, and DHA. Omega-6 FA was defined as ARA and LA intake. Some studies, 
such as that from Lemoine et al., used the most basic formula with only EPA and DHA 
representing omega-3 FA and ARA representing omega-6 FA.21 While there is a  
simplicity to this profile, it does not account for the omega-3 FA that people consume in 
the greatest amount: ALA.32 Additionally, many people consume a variety of foods and, 
thus, not just one type of omega-3 or omega-6 FA. The definitions we used in this study 
are similar to that of Dong et al. and Chen et al., and we suggest this allowed for a more 
complete assessment of omega FA intake.20,23 To support this approach, we found that 
the omega-6:omega-3 ratio was much lower when using the most basic FA profile 
(ARA: EPA+DHA, 5.48) compared to the profile ultimately used in our study 
(ALA+SDA+EPA+DPA+DHA:ARA+LA, 9.79). Although the lower ratio is nutritionally 
desired, we suggest it is a false depiction of omega-3 and omega-6 intake since it does 
 
not account for ALA. Many western diets have an omega-6:omega-3 ratio of 15:1 to 
17:1.19 Some may be as low as 10:1, representing a healthier western diet, but still 
above a ratio considered to be beneficial.36  Although it is believed that at one point our 
diets contained the “ancestral” ratio of 1:1, beneficial ratios have shown to range from 
4:1 to 7:1. 19,28  These ratios, specifically 4:1, have shown to protect against diabetes 
and emotional and cognitive behavior impairment.19,20,27 Thus, a smaller a ratio, or a 
ratio closest to 4:1, is the desired metric. In our study, over 75% of the individuals had a 
ratio of 7:1 or more. 
Because our main aim was to test fiber’s potential synergistic role on omega FA, 
we statistically tested the interaction of fiber with omega FA on respiratory effects.  
Despite our hypothesis of synergism, we found that the fiber and omega FA interactions 
to be nonsignificant. A study by Navarro et al. looked at the effect of the interaction of 
fiber and omega-3 FA (EPA and DHA) on the risk of colorectal cancer in women.37 They 
found the interaction to be nonsignificant, with only high levels of fiber intake having 
protective effects.37 Interestingly, Navarro et al. noted that at low fiber levels an 
interaction with the omega-3 FA was detected, and weakened as fiber levels increased. 
This interaction, however, was no longer significant after correcting for multiple testing.37 
We hypothesize that it is likely we did not find significant associations when comparing 
diet variables to asthma and respiratory symptoms due to the complex interactions of 
the omega FA with one another and fiber. 
 Our study has the distinct advantage in that it addresses the interaction of fiber 
and omega FA intake in relation to asthma. Despite our results not supporting our 
hypothesis of seeing a lower prevalence of asthma and respiratory outcomes with 
 
higher intake of fiber and omega-3 FA, and lower intake of omega-6 FA, our results and 
the complexity of the diet variables with one another support the need for more 
research. Our study has a few limitations. First, the race/ethnicity profile of our study 
population for those with asthma does not match the prevalence seen in the U.S. Those 
with asthma in our population were predominantly non-Hispanic white, while asthma in 
the U.S. is most prevalent in non-Hispanic blacks with a prevalence of 10.6% (versus 
7.6% for non-Hispanic whites).11,29 Other demographics predominantly found in our 
study population such as gender (female), socioeconomic status (in poverty), and BMI 
(overweight/obese) were similar to those of adult asthmatics in the U.S.6,8,11,29,38 
Second, our dietary intakes were measured by dietary recall. NHANES relies on 24-
hour dietary recall interviews in-person for day one and via phone interviews for day 
two. Because these interviews are not substantiated with laboratory diagnostics, there is 
inherent bias and potential for inaccuracy.31 Third, despite much care taken in 
determining dietary intake of FA, there may be misclassification due to lack of isomer 
specification in NHANES, as noted by Chen et al.23 It should also be noted that once a 
FA is consumed, FA metabolism may differ among subjects, thus altering outcomes 
specific to that subject.21 It is suggested that a randomized control trial be designed and 
conducted to compare actual intake versus minimal intake versus levels high intake 
(defined as enough to confer a positive effect on respiratory outcomes). Additionally, it 






In the general U.S. population we found that intake of fiber was associated with 
asthma in bivariate analysis and with cough in multivariable analysis; however, no 
significant association was observed between omega-3 or omega-6 FA intake and 
asthma or asthma-related symptoms. The role of omega-6 FA in inflammation, whether 
pro- or anti-inflammatory, is still not fully understood, but even less is understood about 
the complex relationship between omega-3 and omega-6 FA. The understanding of the 
interaction of fiber and omega FA on asthma and asthma-related symptoms require 
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